Synthesis of Novel Baicalein Amino Acid Derivatives and Biological Evaluation as Neuroprotective Agents. 2019

Xiaohui Jia, and Menglu Jia, and Yuqin Yang, and Di Wang, and Fei Zhou, and Wenxi Zhang, and Xuemei Huang, and Wenbo Guo, and Desheng Cai, and Hongshan Chen, and Jinchai Qi, and Shuqi Zhou, and Haomiao Ren, and Bing Xu, and Tao Ma, and Penglong Wang, and Haimin Lei
School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China. 18811508865@163.com.

Baicalein, a famously effective component of the traditional Chinese medicine Rhizoma Huang Qin (Scutellaria altissima L.), has been proved to have potent neuroprotection and anti-platelet aggregation effects with few side effects. Meanwhile, recent studies have revealed that the introduction of amino acid to baicalein could improve its neuroprotective activity. In the present study, a series of novel baicalein amino acid derivatives were designed, synthesized, and screened for their neuroprotective effect against tert-butyl, hydroperoxide-induced, SH-SY5Y neurotoxicity cells and toxicity on the normal H9C2 cell line by standard methylthiazol tetrazolium (MTT) assay. In addition, all of the newly synthesized compounds were characterized by 1H-NMR, 13C-NMR, and high resolution mass spectrometry (HR-MS). The results showed that most of the compounds provided more potent neuroprotection than baicalein, and were equivalent to the positive drug edaravin. They showed no obvious cytotoxicity on normal H9C2 cells. Notably, the most active compound 8 displayed the highest protective effect (50% effective concentration (EC50) = 4.31 μM) against tert-butyl, hydroperoxide-induced, SH-SY5Y neurotoxicity cells, which was much better than the baicalein (EC50 = 24.77 μM) and edaravin (EC50 = 5.62 μM). Further research on the chick chorioallantoic membrane (CAM) model indicated that compound 8 could significantly increase angiogenesis, which might promote neurovascular proliferation. The detection of apoptosis analysis showed that compound 8 could dramatically alleviate morphological manifestations of cell damage. Moreover, the benzyloxycarbonyl (cbz)-protected baicalein amino acid derivatives showed better neuroprotective activity than the t-Butyloxy carbonyl (boc)-protected derivatives.

UI MeSH Term Description Entries
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002642 Chick Embryo The developmental entity of a fertilized chicken egg (ZYGOTE). The developmental process begins about 24 h before the egg is laid at the BLASTODISC, a small whitish spot on the surface of the EGG YOLK. After 21 days of incubation, the embryo is fully developed before hatching. Embryo, Chick,Chick Embryos,Embryos, Chick
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D043925 Angiogenesis Inducing Agents Agents that induce or stimulate PHYSIOLOGIC ANGIOGENESIS or PATHOLOGIC ANGIOGENESIS. Angiogenesis Inducers,Angiogenesis Effect,Angiogenesis Effects,Angiogenesis Factor,Angiogenesis Stimulating Agents,Angiogenesis Stimulators,Angiogenic Factor,Tumor Angiogenic Factor,Agents, Angiogenesis Inducing,Agents, Angiogenesis Stimulating,Angiogenic Factor, Tumor,Effect, Angiogenesis,Effects, Angiogenesis,Factor, Angiogenesis,Factor, Angiogenic,Factor, Tumor Angiogenic,Inducers, Angiogenesis,Inducing Agents, Angiogenesis,Stimulating Agents, Angiogenesis,Stimulators, Angiogenesis

Related Publications

Xiaohui Jia, and Menglu Jia, and Yuqin Yang, and Di Wang, and Fei Zhou, and Wenxi Zhang, and Xuemei Huang, and Wenbo Guo, and Desheng Cai, and Hongshan Chen, and Jinchai Qi, and Shuqi Zhou, and Haomiao Ren, and Bing Xu, and Tao Ma, and Penglong Wang, and Haimin Lei
April 2008, Journal of agricultural and food chemistry,
Xiaohui Jia, and Menglu Jia, and Yuqin Yang, and Di Wang, and Fei Zhou, and Wenxi Zhang, and Xuemei Huang, and Wenbo Guo, and Desheng Cai, and Hongshan Chen, and Jinchai Qi, and Shuqi Zhou, and Haomiao Ren, and Bing Xu, and Tao Ma, and Penglong Wang, and Haimin Lei
March 2014, Bioorganic & medicinal chemistry letters,
Xiaohui Jia, and Menglu Jia, and Yuqin Yang, and Di Wang, and Fei Zhou, and Wenxi Zhang, and Xuemei Huang, and Wenbo Guo, and Desheng Cai, and Hongshan Chen, and Jinchai Qi, and Shuqi Zhou, and Haomiao Ren, and Bing Xu, and Tao Ma, and Penglong Wang, and Haimin Lei
January 2017, Chemical & pharmaceutical bulletin,
Xiaohui Jia, and Menglu Jia, and Yuqin Yang, and Di Wang, and Fei Zhou, and Wenxi Zhang, and Xuemei Huang, and Wenbo Guo, and Desheng Cai, and Hongshan Chen, and Jinchai Qi, and Shuqi Zhou, and Haomiao Ren, and Bing Xu, and Tao Ma, and Penglong Wang, and Haimin Lei
May 2016, Bioorganic & medicinal chemistry letters,
Xiaohui Jia, and Menglu Jia, and Yuqin Yang, and Di Wang, and Fei Zhou, and Wenxi Zhang, and Xuemei Huang, and Wenbo Guo, and Desheng Cai, and Hongshan Chen, and Jinchai Qi, and Shuqi Zhou, and Haomiao Ren, and Bing Xu, and Tao Ma, and Penglong Wang, and Haimin Lei
June 2017, Journal of medicinal chemistry,
Xiaohui Jia, and Menglu Jia, and Yuqin Yang, and Di Wang, and Fei Zhou, and Wenxi Zhang, and Xuemei Huang, and Wenbo Guo, and Desheng Cai, and Hongshan Chen, and Jinchai Qi, and Shuqi Zhou, and Haomiao Ren, and Bing Xu, and Tao Ma, and Penglong Wang, and Haimin Lei
December 2020, Bioorganic & medicinal chemistry letters,
Xiaohui Jia, and Menglu Jia, and Yuqin Yang, and Di Wang, and Fei Zhou, and Wenxi Zhang, and Xuemei Huang, and Wenbo Guo, and Desheng Cai, and Hongshan Chen, and Jinchai Qi, and Shuqi Zhou, and Haomiao Ren, and Bing Xu, and Tao Ma, and Penglong Wang, and Haimin Lei
July 2019, MedChemComm,
Xiaohui Jia, and Menglu Jia, and Yuqin Yang, and Di Wang, and Fei Zhou, and Wenxi Zhang, and Xuemei Huang, and Wenbo Guo, and Desheng Cai, and Hongshan Chen, and Jinchai Qi, and Shuqi Zhou, and Haomiao Ren, and Bing Xu, and Tao Ma, and Penglong Wang, and Haimin Lei
March 2012, Bioorganic & medicinal chemistry letters,
Xiaohui Jia, and Menglu Jia, and Yuqin Yang, and Di Wang, and Fei Zhou, and Wenxi Zhang, and Xuemei Huang, and Wenbo Guo, and Desheng Cai, and Hongshan Chen, and Jinchai Qi, and Shuqi Zhou, and Haomiao Ren, and Bing Xu, and Tao Ma, and Penglong Wang, and Haimin Lei
June 2012, Archiv der Pharmazie,
Xiaohui Jia, and Menglu Jia, and Yuqin Yang, and Di Wang, and Fei Zhou, and Wenxi Zhang, and Xuemei Huang, and Wenbo Guo, and Desheng Cai, and Hongshan Chen, and Jinchai Qi, and Shuqi Zhou, and Haomiao Ren, and Bing Xu, and Tao Ma, and Penglong Wang, and Haimin Lei
November 2020, Molecules (Basel, Switzerland),
Copied contents to your clipboard!